
Anti-VEGF Tx Seems OK for Eye Disorders No increased risk of systemic adverse events with intravitreal anti-VEGF
Intravitreal anti-VEGF treatments for neovascular age-related macular degeneration (AMD), diabetic macular edema (DME), or retinal vein occlusion did not appear to increase the risk of



